Results 101 to 110 of about 20,876 (147)

Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases. [PDF]

open access: yesHemasphere
Carpinteiro A   +15 more
europepmc   +1 more source

Echocardiographic Markers of Cardiac Response to Therapy in Patients with Light Chain Amyloidosis. [PDF]

open access: yesEchocardiography
Ng D   +7 more
europepmc   +1 more source

Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials. [PDF]

open access: yesJ Clin Oncol
Wechalekar AD   +18 more
europepmc   +1 more source

Hepatic Amyloid Light-Chain Amyloidosis Incidentally Diagnosed via Endoscopic Ultrasound-Guided Liver Biopsy. [PDF]

open access: yesACG Case Rep J
Tsujiguchi Y   +7 more
europepmc   +1 more source

Talquetamab induces deep responses in heavily pre-treated patients with systemic light-chain amyloidosis. [PDF]

open access: yesAnn Hematol
Shragai T   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy